About Novapri Lifescience Private Limited
Data last updated:
Novapri Lifescience Private Limited is a private limited company based in Bhiwandi, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2019PTC328092. Its GSTIN is 27AAGCN6098Q1ZG (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Neha Daga and Pankaj Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhiwandi, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.98 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹5.23 Lakh (net margin 52.4%) and EBITDA of ₹6.99 Lakh (EBITDA margin 70.1%). Revenue has declined at a compounded annual rate (CAGR) of 42% over three years.
For more details, the company can be reached via its website primepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressGala No. 6 Second Floor Manish Compound Building No.1 Dapode Road Rahanal Bhi, Wandi, Bhiwandi, Maharashtra, India – 421302
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Novapri Lifescience Private Limited
The main business activity of Novapri Lifescience is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Novapri Lifescience Private Limited FY 2025 filings available
Novapri Lifescience Private Limited reported revenue of ₹9.98 Lakh (up 655% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Novapri Lifescience Private Limited
Revenue rose 655% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 42%. EBITDA rose 982% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Novapri Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.99 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.23 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Novapri Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 70.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 52.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Novapri Lifescience are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Novapri Lifescience Private Limited
Novapri Lifescience Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Human health activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Universus Health Services Private Limited | ₹10.2 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | New Delhi, Delhi, India |
| Devottar Seva Foundation | ₹10.19 Lakh (FY 2025) | •••• | •••• | 1009074.0% | •••• | Bhopal, Madhya Pradesh, India |
| Altry Foundation | ₹10.18 Lakh (FY 2024) | •••• | •••• | -60.0% | •••• | Mumbai, Maharashtra, India |
| Eyegenics Visioncare Private Limited | ₹10.12 Lakh (FY 2025) | •••• | •••• | 105.0% | •••• | Bhubaneswar, Odisha, India |
| Lukahealthcare Private Limited | ₹10 Lakh (FY 2025) | •••• | •••• | 75.0% | •••• | Alappuzha, Kerala, India |
| Novapri Lifescience Private Limited this company | ₹9.98 Lakh (FY 2025) | •••• | •••• | 655.0% | •••• | Bhiwandi, Maharashtra, India |
| Shabnam Ayurveda Private Limited | ₹9.97 Lakh (FY 2024) | •••• | •••• | -10.0% | •••• | Mohali, Punjab, India |
| Sri Revana Siddeshwara Health Systems Private Limited | ₹9.95 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | Bangalore, Karnataka, India |
| Medifinder Healthcare Solutions Private Limited | ₹9.92 Lakh (FY 2025) | •••• | •••• | •••• | Panvel, Maharashtra, India | |
| Joash Pharmaceutical Private Limited | ₹9.91 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Siliguri, West Bengal, India |
| Strango Healthtech Private Limited | ₹9.88 Lakh (FY 2025) | •••• | •••• | •••• | Hisar, Haryana, India |
Peers are the five companies nearest above and the five nearest below Novapri Lifescience by revenue in the same principal business activity (Human health activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Novapri Lifescience Private Limited
Novapri Lifescience Private Limited is audited by HEGDE & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| HEGDE & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Novapri Lifescience Private Limited
Novapri Lifescience has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neha Daga Also directs: Smart Advisory and Technology Private Limited | Director | 30 Sep 2021 | 5 Years 0 Months | Current |
| Pankaj Arora | Director | 16 Jul 2019 | 7 Years 2 Months | Current |
| Nidhi Arora | Director | 16 Jul 2019 | 7 Years 2 Months | Current |
Ownership and Shareholding of Novapri Lifescience Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Novapri Lifescience Private Limited
Novapri Lifescience Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Novapri Lifescience Private Limited
Employment history and EPFO contributions of people linked to Novapri Lifescience.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Novapri Lifescience Private Limited
Novapri Lifescience Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Ashish Anil Vora ceased to be Director on 09 Nov 2021.
Credit Ratings, Litigation & Regulatory Alerts for Novapri Lifescience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Novapri Lifescience Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Novapri Lifescience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Novapri Lifescience Private Limited
Novapri Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCN6098Q1ZG | Maharashtra | Active | 06 Aug 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Novapri Lifescience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novapri Lifescience Private Limited
Novapri Lifescience is an active private limited company based in Bhiwandi, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 July 2019 (7+ years old) and is registered under CIN U51909MH2019PTC328092.
Novapri Lifescience reported revenue of ₹9.98 Lakh for FY 2025 (up 655% YoY).
Novapri Lifescience has 3 current directors:
- Neha Daga - Director
- Pankaj Arora - Director
- Nidhi Arora - Director
Novapri Lifescience reported a net profit of ₹5.23 Lakh (net margin 52.4%) and EBITDA of ₹6.99 Lakh (EBITDA margin 70.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Novapri Lifescience is -42% over three years. In the latest year (FY 2025) revenue rose 655%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Novapri Lifescience is 27AAGCN6098Q1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Novapri Lifescience is U51909MH2019PTC328092. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novapri Lifescience was incorporated on 16 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Novapri Lifescience by revenue are Universus Health Services Private Limited, Devottar Seva Foundation, Altry Foundation, Eyegenics Visioncare Private Limited, Lukahealthcare Private Limited and 5 more, all in the same principal business activity (Human health activities).
Ashish Anil Vora ceased to be Director on 09 Nov 2021. Devang Subodh Thakar ceased to be Director on 09 Nov 2021. Neha Daga was appointed as Director on 30 Sep 2021. Novapri Lifescience has 5 board changes on record in total.
Novapri Lifescience can be reached through the website primepharma.com. Its registered office is in Bhiwandi, Maharashtra, India.